Actively Recruiting
Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation
Led by University of Michigan Rogel Cancer Center · Updated on 2026-05-04
10
Participants Needed
1
Research Sites
205 weeks
Total Duration
On this page
Sponsors
U
University of Michigan Rogel Cancer Center
Lead Sponsor
N
National Institutes of Health (NIH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
To assess the feasibility and preliminary effectiveness of a Cardio-Oncology Prehabilitation program in patients at high-risk of developing Cardiovascular (CV) events in improving Cardiorespiratory fitness (CRF) and reducing acute CV complications in Hematopoietic stem cell transplant (HSCT) recipients.
CONDITIONS
Official Title
Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult 18 years or older
- Referred for Hematopoietic Stem Cell Transplant evaluation
- Have at least one cardiovascular risk factor such as hypertension, hyperlipidemia, atrial fibrillation, obesity, heart failure, history of coronary artery disease, or diabetes
- Able to walk without assistance
- Able to understand and willing to sign informed consent
- Able to use Polar Flow heart rate application
You will not qualify if you...
- Severe anemia (hemoglobin less than 7 gm/dl)
- Untreated high-risk coronary artery disease (left main, triple vessel disease)
- Severe aortic stenosis
- Recent fracture as reported by the patient
- Significant balance problems
- Severe pain during basic movements
- Unable to walk without assistance or exercise
- New York Heart Association class IV heart failure
- Adults unable to give consent, pregnant women, and prisoners
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, United States, 48109
Actively Recruiting
Research Team
C
Cancer AnswerLine
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here